| Product NDC: | 25021-116 |
| Proprietary Name: | Bacitracin |
| Non Proprietary Name: | bacitracin |
| Active Ingredient(s): | 50000 [iU]/10mL & nbsp; bacitracin |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-116 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090211 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100810 |
| Package NDC: | 25021-116-30 |
| Package Description: | 1 VIAL in 1 CARTON (25021-116-30) > 10 mL in 1 VIAL |
| NDC Code | 25021-116-30 |
| Proprietary Name | Bacitracin |
| Package Description | 1 VIAL in 1 CARTON (25021-116-30) > 10 mL in 1 VIAL |
| Product NDC | 25021-116 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | bacitracin |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20100810 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | BACITRACIN |
| Strength Number | 50000 |
| Strength Unit | [iU]/10mL |
| Pharmaceutical Classes | Decreased Cell Wall Synthesis & Repair [PE] |